Regulation

Issue Number

Latest documents

• COVID-19 and Opioid Addiction Treatment.
• Pursuing Biological and Chemical Weapons Details through FOIA.
• Defending Western Civ.
• Trump's Regulatory Legacy: A First Draft: Despite the headlines, the Trump administration will likely have little lasting effect on federal regulation.
• Are We 'Paying Twice' for Pharmaceuticals? The use of prizes could resolve concerns that drugmakers receive improper rents for their discoveries.
• Assessing the Revolution in Antitrust: New learning and evidence on market concentration do not justify a return to the dark ages of antitrust and regulation.
• Bad Energy Legislation in New Mexico.
• The Costs of Closing DACA Initial Enrollments.
• Climate Change.
• Spreading Like Wildfire: Economics and wildfire policy offer useful lessons for COVID-19 response.

Featured documents

• Deregulation Under Trump: Despite claims of broad deregulation, the administrations hallmark, has been little regulatory activity.
• Getting Out of Your Business: Cities nationwide are making it a crime to work from home.
• The Return of Antitrust? New arguments that American industries are harmfully concentrated are as dubious as last century's pre-Chicago claims.
• Paying Beneficiaries, Not Providers: Transforming Medicaid and Medicare into poverty-fighting programs would greatly improve Americans' health.
• The Trump Economy: Three Years of Volatile Continuity: Entering 2020, the country was badly prepared for a major economic shock.
• Many Different Sorts of Democracy.
• The One-Percenter State.
• The Regressive Effects of Child-Care Regulations: More strenuous requirements raise child-care prices but have little apparent effect on quality.
• Utility Energy Efficiency Initiatives Are Good Policy: These programs address important market failures and have been shown to be cost-effective.
• A Bridge to Collectivism.